MX383202B - Sondas para la proyección de imagen de la proteína huntingtina. - Google Patents

Sondas para la proyección de imagen de la proteína huntingtina.

Info

Publication number
MX383202B
MX383202B MX2017002704A MX2017002704A MX383202B MX 383202 B MX383202 B MX 383202B MX 2017002704 A MX2017002704 A MX 2017002704A MX 2017002704 A MX2017002704 A MX 2017002704A MX 383202 B MX383202 B MX 383202B
Authority
MX
Mexico
Prior art keywords
imaging
probes
huntingtin protein
huntingtin
protein
Prior art date
Application number
MX2017002704A
Other languages
English (en)
Spanish (es)
Other versions
MX2017002704A (es
Inventor
Celia Dominguez
Christopher John Brown
Daniel Clark-Frew
John Wityak
Jonathan Bard
Sarah Hayes
Thomas Martin Krülle
Original Assignee
Chdi Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chdi Foundation Inc filed Critical Chdi Foundation Inc
Publication of MX2017002704A publication Critical patent/MX2017002704A/es
Publication of MX383202B publication Critical patent/MX383202B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
MX2017002704A 2014-08-29 2015-08-28 Sondas para la proyección de imagen de la proteína huntingtina. MX383202B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462043644P 2014-08-29 2014-08-29
PCT/US2015/047396 WO2016033436A1 (en) 2014-08-29 2015-08-28 Probes for imaging huntingtin protein

Publications (2)

Publication Number Publication Date
MX2017002704A MX2017002704A (es) 2017-10-23
MX383202B true MX383202B (es) 2025-03-13

Family

ID=55400644

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017002704A MX383202B (es) 2014-08-29 2015-08-28 Sondas para la proyección de imagen de la proteína huntingtina.
MX2021005891A MX2021005891A (es) 2014-08-29 2017-02-28 Sondas para la proyeccion de imagen de la proteina huntingtina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021005891A MX2021005891A (es) 2014-08-29 2017-02-28 Sondas para la proyeccion de imagen de la proteina huntingtina.

Country Status (20)

Country Link
US (2) US11071793B2 (cg-RX-API-DMAC7.html)
EP (1) EP3186241B1 (cg-RX-API-DMAC7.html)
JP (3) JP2017527559A (cg-RX-API-DMAC7.html)
KR (1) KR102410760B1 (cg-RX-API-DMAC7.html)
CN (2) CN107074817B (cg-RX-API-DMAC7.html)
AU (1) AU2015308765B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017004136B1 (cg-RX-API-DMAC7.html)
CA (1) CA2959531C (cg-RX-API-DMAC7.html)
DK (1) DK3186241T3 (cg-RX-API-DMAC7.html)
EA (1) EA037275B1 (cg-RX-API-DMAC7.html)
ES (1) ES2841746T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20202032T1 (cg-RX-API-DMAC7.html)
HU (1) HUE052892T2 (cg-RX-API-DMAC7.html)
IL (1) IL250805B (cg-RX-API-DMAC7.html)
MX (2) MX383202B (cg-RX-API-DMAC7.html)
PL (1) PL3186241T3 (cg-RX-API-DMAC7.html)
PT (1) PT3186241T (cg-RX-API-DMAC7.html)
SG (1) SG11201701578YA (cg-RX-API-DMAC7.html)
SI (1) SI3186241T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016033436A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015308709B2 (en) 2014-08-29 2020-01-02 Chdi Foundation, Inc. Probes for imaging huntingtin protein
CN107108534B (zh) 2014-08-29 2023-05-09 Chdi基金会股份有限公司 用于成像亨廷顿蛋白的探针
SI3197277T1 (sl) 2014-08-29 2022-04-29 Chdi Foundation, Inc. Sonde za slikanje proteina huntingtina
CA2959531C (en) 2014-08-29 2023-01-10 Chdi Foundation, Inc. Probes for imaging huntingtin protein
PL3340796T3 (pl) 2015-08-28 2022-02-21 Chdi Foundation, Inc. Sondy do obrazowania białka huntingtyny
EP3509587B1 (en) 2016-09-12 2023-12-06 Valo Health, Inc. Monocyclic compounds useful as gpr120 modulators
JP7065081B2 (ja) * 2016-09-12 2022-05-11 インテグラル ヘルス, インコーポレイテッド Gpr120モジュレーターとして有用な二環式化合物
US11389438B2 (en) 2019-02-25 2022-07-19 Chdi Foundation, Inc. Compounds for targeting mutant huntingtin protein and uses thereof
WO2021127265A1 (en) * 2019-12-18 2021-06-24 Chdi Foundation, Inc. Compounds and probes for imaging huntingtin protein
AR122586A1 (es) * 2020-06-11 2022-09-21 Chdi Foundation Inc Compuestos heterocíclicos y agentes de imagen para la imagen de la proteína huntingtina
MX2023011888A (es) * 2021-04-08 2023-12-06 Chdi Foundation Inc Compuestos de isoindolinona y agentes de formación de imágenes para la obtencion de imágenes de la proteína huntingtina.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726197A (en) * 1992-11-02 1998-03-10 Syntex (U.S.A.) Inc. Isoindolinyl derivatives
WO2000076969A1 (en) 1999-06-10 2000-12-21 Warner-Lambert Company Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
KR101011657B1 (ko) * 2002-03-01 2011-01-28 다케다 야쿠힌 고교 가부시키가이샤 항우울제
US7968569B2 (en) 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
US7320992B2 (en) * 2003-08-25 2008-01-22 Amgen Inc. Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
US8110681B2 (en) * 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
EP2215074B1 (en) 2007-09-27 2014-02-19 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
JP5632612B2 (ja) * 2007-12-05 2014-11-26 あすか製薬株式会社 ラクタム化合物又はその塩及びppar活性化剤
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
WO2013161312A1 (en) * 2012-04-25 2013-10-31 Raqualia Pharma Inc. Pyrrolopyridinone derivatives as ttx-s blockers
JP6507157B2 (ja) * 2013-10-07 2019-04-24 カドモン コーポレイション,リミティド ライアビリティ カンパニー Rhoキナーゼ阻害剤
CN107108534B (zh) 2014-08-29 2023-05-09 Chdi基金会股份有限公司 用于成像亨廷顿蛋白的探针
AU2015308709B2 (en) 2014-08-29 2020-01-02 Chdi Foundation, Inc. Probes for imaging huntingtin protein
SI3197277T1 (sl) 2014-08-29 2022-04-29 Chdi Foundation, Inc. Sonde za slikanje proteina huntingtina
CA2959531C (en) 2014-08-29 2023-01-10 Chdi Foundation, Inc. Probes for imaging huntingtin protein
PL3340796T3 (pl) 2015-08-28 2022-02-21 Chdi Foundation, Inc. Sondy do obrazowania białka huntingtyny

Also Published As

Publication number Publication date
MX2017002704A (es) 2017-10-23
US11071793B2 (en) 2021-07-27
JP2017527559A (ja) 2017-09-21
EA201790432A1 (ru) 2017-09-29
CN107074817B (zh) 2023-12-15
IL250805B (en) 2020-08-31
CN118005611A (zh) 2024-05-10
US12036291B2 (en) 2024-07-16
MX2021005891A (es) 2021-06-23
EA037275B1 (ru) 2021-03-03
SI3186241T1 (sl) 2021-03-31
JP6843282B2 (ja) 2021-03-17
CN107074817A (zh) 2017-08-18
CA2959531A1 (en) 2016-03-03
EP3186241B1 (en) 2020-10-07
JP7042940B2 (ja) 2022-03-28
IL250805A0 (en) 2017-04-30
HUE052892T2 (hu) 2021-05-28
KR20170047348A (ko) 2017-05-04
AU2015308765A1 (en) 2017-03-23
US20210379211A1 (en) 2021-12-09
US20170281804A1 (en) 2017-10-05
KR102410760B1 (ko) 2022-06-20
EP3186241A4 (en) 2018-04-18
PL3186241T3 (pl) 2021-05-17
AU2015308765B2 (en) 2020-06-04
HRP20202032T1 (hr) 2021-02-19
BR112017004136B1 (pt) 2022-05-03
PT3186241T (pt) 2021-01-08
CA2959531C (en) 2023-01-10
JP2020079272A (ja) 2020-05-28
EP3186241A1 (en) 2017-07-05
SG11201701578YA (en) 2017-03-30
ES2841746T3 (es) 2021-07-09
WO2016033436A1 (en) 2016-03-03
DK3186241T3 (da) 2021-01-11
JP2021088584A (ja) 2021-06-10
BR112017004136A2 (pt) 2017-12-12

Similar Documents

Publication Publication Date Title
MX380810B (es) Sondas para la proyección de imagen de la proteína huntingtina.
IL282304A (en) Topical pharmaceutical compositions
IL270514B (en) Agricultural compositions
MX383202B (es) Sondas para la proyección de imagen de la proteína huntingtina.
FIC20240025I1 (fi) Momelotinibi, mukaanlukien momelotinibidihydrokloridimonohydraatti
MX386798B (es) Sondas para la proyección de imagen de la proteína huntingtina.
CL2016001871A1 (es) Anticuerpos humanos para pd-1
EP3547968A4 (en) PROSTHESIS OBTAINED BY TISSUE ENGINEERING
MX2017002705A (es) Sondas para la proyección de imagen de la proteína huntingtina.
HUE053939T2 (hu) Deuterált heterociklikus vegyületek és képalkotó kontrasztanyagként való használatuk
CY1121464T1 (el) Στεροειδης ενωση για χρηση στην αντιμετωπιση της ηπατικης εγκεφαλοπαθειας
MX382156B (es) Sondas para formar imagenes de proteina de huntingtina.
EP3898217C0 (en) PAPER TISSUE PRODUCT
LT3113778T (lt) Piridazino dariniai, skirti naudoti ataksinio sutrikimo profilaktikai arba gydymui
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
EP3595670A4 (en) MEDICINAL-POLYMER CONJUGATE
EP3592891C0 (en) FABRICS
BR112017026807A2 (pt) agentes solubilizantes para compostos ativos funcionais
ITUB20153201A1 (it) Kit per la chirurgia episclerale.
PT3148582T (pt) Fármaco antirretroviral dirigido para retrovírus endógenos humanos
SI3652187T1 (sl) Izboljšan postopek za pripravo imetelstata
EP3677210A4 (en) SURGICAL SYSTEM
IT201700111990A1 (it) Scambiatore per uso medicale
ES1162938Y (es) Producto higiénico de uso personal
EP3721000A4 (en) Fabric